At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
KVUE Kenvue Inc
Not Yet Opened 08-05 16:00:00 EDT
19.67
+0.12
+0.61%
盘后19.70
+0.03+0.13%
19:52 EDT
High19.67Low19.07Vol32.81M
Open19.53D1 Closing19.55Amplitude3.09%
Mkt Cap37.69BTradable Cap37.21BTotal Shares1.92B
T/O638.13MT/O Rate1.73%Tradable Shares1.89B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Kenvue Inc Expected to Post Earnings of 32 Cents a Share - Earnings Preview
Reuters  ·  08-04 22:27
Kenvue Inc Expected to Post Earnings of 32 Cents a Share - Earnings Preview
Kenvue Inc. Stock Falls Monday, Underperforms Market
Dow Jones  ·  08-04 04:55
Kenvue Inc. Stock Falls Monday, Underperforms Market
Earning Preview: Kenvue Inc this quarter’s revenue is expected to increase by 2.94%, and institutional views are neutral
Earnings Agent  ·  07-31
Earning Preview: Kenvue Inc this quarter’s revenue is expected to increase by 2.94%, and institutional views are neutral
Kenvue Inc. Stock Falls Thursday, Underperforms Market
Dow Jones  ·  07-31
Kenvue Inc. Stock Falls Thursday, Underperforms Market
Drugmakers, Retailers Must Face 'maximum Strength' Claim in Decongestant False Ad Litigation in US
Reuters  ·  07-31
Drugmakers, Retailers Must Face 'maximum Strength' Claim in Decongestant False Ad Litigation in US
NYSE Order Imbalance 2211216.0 Shares on Buy Side
THOMSON REUTERS  ·  07-30
NYSE Order Imbalance 2211216.0 Shares on Buy Side
Kenvue Increases Quarterly Dividend to $0.21 from $0.2075 a Share; Payable Aug. 26 to Holders of Record Aug. 12
MT Newswires Live  ·  07-29
Kenvue Increases Quarterly Dividend to $0.21 from $0.2075 a Share; Payable Aug. 26 to Holders of Record Aug. 12
Kenvue Maintain Royal Dividend Status with 1.2% Increase
Dow Jones  ·  07-29
Kenvue Maintain Royal Dividend Status with 1.2% Increase
Kenvue Raises Quarterly Dividend to $0.21 a Share
Reuters  ·  07-29
Kenvue Raises Quarterly Dividend to $0.21 a Share
Kenvue - Declares Qtrly Dividend of $0.21 Per Share, up 1.2% from Prior Dividend
THOMSON REUTERS  ·  07-29
Kenvue - Declares Qtrly Dividend of $0.21 Per Share, up 1.2% from Prior Dividend
Kenvue Increases Quarterly Cash Dividend
THOMSON REUTERS  ·  07-29
Kenvue Increases Quarterly Cash Dividend
Kenvue Inc. Stock Rises Monday, Outperforms Market
Dow Jones  ·  07-28
Kenvue Inc. Stock Rises Monday, Outperforms Market
Kenvue (KVUE) Gains FDA Backing As Valuation Questions Return
Simply Wall St.  ·  07-26
Kenvue (KVUE) Gains FDA Backing As Valuation Questions Return
Kenvue Says FDA Has Granted Tylenol Three-year Exclusivity for New OTC Formulation
Reuters  ·  07-25
Kenvue Says FDA Has Granted Tylenol Three-year Exclusivity for New OTC Formulation
Kenvue - FDA Grants Tylenol Three-year Exclusivity for New Otc Formulation
THOMSON REUTERS  ·  07-25
Kenvue - FDA Grants Tylenol Three-year Exclusivity for New Otc Formulation
Kenvue - Tylenol with Naproxen to be Available Soon at Major U.S. Retailers
THOMSON REUTERS  ·  07-25
Kenvue - Tylenol with Naproxen to be Available Soon at Major U.S. Retailers
FDA Approves Tylenol® with Naproxen, the First and Only Over-the-counter Fixed-dose Combination of Acetaminophen (650 Mg) and Naproxen Sodium (220 Mg)
THOMSON REUTERS  ·  07-25
FDA Approves Tylenol® with Naproxen, the First and Only Over-the-counter Fixed-dose Combination of Acetaminophen (650 Mg) and Naproxen Sodium (220 Mg)
Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)?
Simply Wall St.  ·  07-24
Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)?
Kenvue's Tylenol With Naproxen Combination Tablet Gets FDA Approval for Pain Relief
MT Newswires Live  ·  07-24
Kenvue's Tylenol With Naproxen Combination Tablet Gets FDA Approval for Pain Relief
US FDA - Approves Tylenol with Naproxen, First Otc Acetaminophen/naproxen Combination for 12-hour Pain Relief
THOMSON REUTERS  ·  07-24
US FDA - Approves Tylenol with Naproxen, First Otc Acetaminophen/naproxen Combination for 12-hour Pain Relief

Introduction

Company Name.
Kenvue Inc
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Issue price:
--